References
- Mol BMJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387:999–1011.
- American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–31.
- Werner EF, Hauspurg AK, Rouse DJ. A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol. 2015;126:1242–50.
- Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682–9.
- Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985;152:335–40.
- Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009;24:147–58.
- Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22.
- Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol. 1953;7:320–38.
- Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2:656–63.
- Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet. 2005;365:785–99.
- Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF. An epidemiologic study of contraception and preeclampsia. JAMA. 1989;262:3143–7.
- Einarsson JI, Sangi-Haghpeykar H, Gardner MO. Sperm exposure and development of preeclampsia. Am J Obstet Gynecol. 2003;188:1241–3.
- Wang JX, Knottnerus AM, Schuit G, et al. Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet. 2002;359:673–4.
- Tubbergen P, Lachmeijer AM, Althuisius SM, et al. Change in paternity: a risk factor for preeclampsia in multiparous women? J Reprod Immunol. 1999;45:81–8.
- Dekker G, Robillard PY. The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis J Reprod Immunol. 2003;59:245–51.
- Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 2001;344:867–72.
- Mogren I, Hogberg U, Winkvist A, Stenlund H. Familial occurrence of preeclampsia. Epidemiology. 1999;10:518–22.
- Need J, Bell B, Meffin E, Jones WR. Pre-eclampsia in pregnancies from donor inseminations. J Reprod Immunol. 1983;5:329–38.
- Smith GN, Walker M, Tessier JL, Millar KG. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol. 1997;177:455–8.
- Hoy J, Venn A, Halliday J, et al. Perinatal and obstetric outcomes of donor insemination using cryopreserved semen in Victoria, Australia. Hum Reprod. 1999;14:1760–4.
- Sauer MV, Paulson RJ, Lobo RA. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med. 1990;323:1157–60.
- Blanchette H. Obstetric performance of patients after oocyte donation. Am J Obstet Gynecol. 1993;168:1803–9.
- Serhal PF, Craft I. Immune basis for preeclampsia: evidence from oocyte recipients. Lancet. 1987;330:744.
- Serhal PF, Craft I. Oocyte donation in 61 patients. Lancet. 1989;1:1185–7.
- Pados G, Camus M, VanSteirteghem A, et al. The evolution and outcome of pregnancies from oocyte donation. Hum Reprod. 1994;9:538–42.
- Abdalla HI, Billett A, Kan AKS, et al. Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol. 1998;105:332–7.
- Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103:551–63.
- Lee MS, Cantonwine D, Little SE, et al. Angiogenic markers in pregnancies conceived through in vitro fertilization. Am J Obstet Gynecol. 2015;213:212.e1–8.
- Yogev Y, Melamed N, Bardin R, et al. Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol. 2010;203:558.e1–7.
- Porreco RP, Schoolcraft CL, Schoolcraft WB. Pregnancy outcome following donor embryo replacement. J Matern Fetal Med. 1997;6:237–40. [9260123]
- Porreco RP, Harden L, Gambotto M, Shapiro H. Expectation of pregnancy outcome among mature women. Am J Obstet Gynecol. 2005;192:38–41.
- Keegan DA, Krey LC, Chang HC, Noyes N. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes. Fertil Steril. 2007;87:776–81.
- Wiggins DA, Main E. Outcomes of pregnancies achieved by donor egg in vitro fertilization-a comparison with standard in vitro fertilization pregnancies. Am J Obstet Gynecol. 2005;192:2002–8.
- Krieg SA, Henne MB, Westphal LM. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertil Steril. 2008;90:65–70.
- Klatsky PC, Delaney SS, Caughey AB, et al. The role of embryonic origin in preeclampsia: a comparison of autologous in vitro fertilization and ovum donor pregnancies. Obstet Gynecol. 2010;116:1387–92.
- Malchau SS, Loft A, Larsen EC, et al. Perinatal outcomes in 375 children born after oocyte donation; a Danish national cohort study. Fertil Steril. 2013;99:1637–43.
- Levron Y, Dviri M, Segol I, et al. The 'immunologic theory' of preeclampsia revisited: a lesson from donor oocyte gestations. Am J Obstet Gynecol. 2014;211:383.e1–5.
- Wennerholm UB, Nejdet S, Kallen K, Thurin A. Obstetric outcome after oocyte donation (OD). Am J Obstet Gynecol. 2015;212:S52. Abstract 76.
- Masoudian P, Nasr A, deNanassy J, et al. Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214:328–39.
- Robillard PY, Dekker G, Iacobelli S, Chaouat G. An essay of reflection: why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology? J Reprod Immunol. 2016;114:44–7.